448 related articles for article (PubMed ID: 26731268)
1. The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome.
Kelley ST; Skarra DV; Rivera AJ; Thackray VG
PLoS One; 2016; 11(1):e0146509. PubMed ID: 26731268
[TBL] [Abstract][Full Text] [Related]
2. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
[TBL] [Abstract][Full Text] [Related]
3. Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice.
Torres PJ; Skarra DV; Ho BS; Sau L; Anvar AR; Kelley ST; Thackray VG
BMC Microbiol; 2019 Mar; 19(1):57. PubMed ID: 30871463
[TBL] [Abstract][Full Text] [Related]
4. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
5. Sex, Microbes, and Polycystic Ovary Syndrome.
Thackray VG
Trends Endocrinol Metab; 2019 Jan; 30(1):54-65. PubMed ID: 30503354
[TBL] [Abstract][Full Text] [Related]
6. Association between Polycystic Ovary Syndrome and Gut Microbiota.
Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
9. Effects of Soy Isoflavones, Resistant Starch and Antibiotics on Polycystic Ovary Syndrome (PCOS)-Like Features in Letrozole-Treated Rats.
Liyanage GSG; Inoue R; Fujitani M; Ishijima T; Shibutani T; Abe K; Kishida T; Okada S
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836015
[TBL] [Abstract][Full Text] [Related]
10. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
[TBL] [Abstract][Full Text] [Related]
11. Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome.
Pieczyńska-Zając JM; Malinowska AM; Pruszyńska-Oszmałek E; Kołodziejski PA; Drzymała-Czyż S; Bajerska J
Nutrition; 2024 Aug; 124():112450. PubMed ID: 38669829
[TBL] [Abstract][Full Text] [Related]
12. Effect of the ketogenic diet on gut microbiome composition and metabolomics in polycystic ovarian syndrome rats induced by letrozole and a high-fat diet.
Wang R; Zhao Y; Fang X; Miao C; Ren N; Chen Y; Cheng W; Zhang Q
Nutrition; 2023 Oct; 114():112127. PubMed ID: 37441825
[TBL] [Abstract][Full Text] [Related]
13. The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits.
Lüll K; Arffman RK; Sola-Leyva A; Molina NM; Aasmets O; Herzig KH; Plaza-Díaz J; Franks S; Morin-Papunen L; Tapanainen JS; Salumets A; Altmäe S; Piltonen TT; Org E
J Clin Endocrinol Metab; 2021 Mar; 106(3):858-871. PubMed ID: 33205157
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
15. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
16. Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.
Zheng Y; Yu J; Liang C; Li S; Wen X; Li Y
Bioprocess Biosyst Eng; 2021 May; 44(5):953-964. PubMed ID: 32157446
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
18. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
[TBL] [Abstract][Full Text] [Related]
19. The interplay between PCOS pathology and diet on gut microbiota in a mouse model.
Rodriguez Paris V; Wong XYD; Solon-Biet SM; Edwards MC; Aflatounian A; Gilchrist RB; Simpson SJ; Handelsman DJ; Kaakoush NO; Walters KA
Gut Microbes; 2022; 14(1):2085961. PubMed ID: 35787106
[TBL] [Abstract][Full Text] [Related]
20. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]